(2E)-Hexenoic Acid

(2E)-Hexenoic Acid

SCHEMBL29211309

CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.CCCC=CC(=O)O.NCCO.O=P(O)(O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of (2E)-Hexenoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 4/20 0.43
GABRR2 P28476 2/20 0.43
BLM P54132 2/20 0.43
GABRR3 A8MPY1 1/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
APEX1 P27695 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
PTPN1 P18031 1/20 0.36
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GABBR2 O75899 1/20 0.33
GABBR1 Q9UBS5 1/20 0.33
PPARA Q07869 2/20 0.33
HCAR2 Q8TDS4 1/20 0.32
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(2E)-Hexenoic Acid SCHEMBL27903034 0.92 GABRR1 (0.50) GABRR1GABRR2BLMGABRR3LMNA
(2E)-Hexenoic Acid SCHEMBL28805831 0.84 TSHR (0.54) GABRR1GABRR2BLMGABRR3LMNA
(2E)-Hexenoic Acid SCHEMBL29006108 0.82 TSHR (0.44) GABRR1GABRR2BLMGABRR3LMNA
Monoethanolamine SCHEMBL28161971 0.80 PTPN1 (0.57) BLMLMNAAPEX1NPSR1TDP1
Monoethanolamine SCHEMBL1835962 0.80 PTPN1 (0.57) BLMLMNAAPEX1NPSR1TDP1
(2E)-Hexenoic Acid SCHEMBL28649890 0.80 LPAR3 (0.46) GABRR1GABRR2BLMGABRR3LMNA
(2E)-Hexenoic Acid SCHEMBL3048610 0.79 TSHR (0.50) GABRR1GABRR2BLMGABRR3LMNA
(2E)-Hexenoic Acid SCHEMBL23615 0.79
(2E)-Hexenoic Acid SCHEMBL23614 0.79
(2E)-Hexenoic Acid SCHEMBL27373174 0.79 TSHR (0.50) GABRR1GABRR2BLMGABRR3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113677349-B Structured molecular carriers for anti-inflammatory compounds and uses thereof 克洛德贝纳尔-里昂第一大学 2024-03-19 CN disclosed